echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Sci Immuno Back-to-back knowledge update – expansion of memory T cells at secondary infection does not come from CD103+ T cells

    Sci Immuno Back-to-back knowledge update – expansion of memory T cells at secondary infection does not come from CD103+ T cells

    • Last Update: 2022-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Written by | Snow Moon

    Editor-in-charge | Most memory
    T cells are localized within tissues, called tissue-resident memory T (TRM), and are acyclic cells
    .
    TRM provides optimal protection
    against specific or viral infections by localizing near target cells.
    TRM can also play other important roles in tissues, participating in tissue protection and homeostasis maintenance
    by responding to homologous antigens or inflammatory signals.
    Compared to circulating memory T cells, TRM has a unique transcriptional profile that expresses integrins and homing receptors
    that promote tissue residency.
    CD103 can bind to E-cadherin in epithelial cells, and most CD8+ TRM cells at the barrier site express CD103, which resides in
    tissues.
    With its unique phenotype and importance for body protection, TRM is an ideal target for vaccines and immunotherapies
    .
    However, it is unclear
    whether TRM is irreversible in tissues and the effect of secondary infection on TRM migration and longevity.
    Questions about TRM stability and function are difficult to answer due to the difficulty of distinguishing between truly resident TRMs in tissues and foreign-infiltrated non-resident cells
    .

    Recently, Science Immunology published two articles on the production of intestinal TRM cells and the changes in the fate of TRM cells after secondary infection: Tessa Bergsbaken's team from the Medical College of New Jersey published a paper titled CD103 fate mapping reveals that intestinal CD103−tissue-resident memory T cells are the primary responders to secondary infection
    .


    The Dietmar Zehn team from the Technical University of Munich has published a report entitled Secondary infections rejuvenate the intestinal CD103+ tissue-resident memory T cell Pool's article
    .
    Both articles analyze the heterogeneity and functional characteristics of CD8+TRM in the gut after secondary infection and the source of expansion of the memory cell bank
    .


    Both studies used CD103-CreERT2/flox-STOP-flox fluorescent reporters/OT-1 mice
    .
    The authors infected mice with LCMV or Yptb and then adopted CD8+ T cells into uninfected mice
    .
    Mice infected with adoptive cells undergo LM-OVA, LCMV or Yptb infection
    .
    Analysis of cells in the gut revealed no significant change in the number of TRMs tracked by lineages, nor did they expand or migrate out of the gut
    .
    However, CD103-CD8+ T cells in the intestine are significantly expanded and new CD103+ TRMs
    are produced.
    This suggests that CD103+ TRM cells do not promote the expansion of the T cell pool in the event of secondary infection
    .
    The authors also used CD103-CreERT2-DTR-floxed mice to remove CD103-T cells, while CD103+TRM remained intact
    .
    The analysis found that CD103+TRM still did not amplify
    after secondary infection.
    This suggests that the lack of amplification effect of CD103+TRM is intrinsic and independent
    of competition with other cells.

    Next, the authors explored whether CD103- cells were different from
    the original CD103+ cells.
    The authors first analyzed reactivity to antigens as well as differences
    in cytokine expression.
    The results showed that CD103-T cells had obvious TCR-antigen interaction after infection, while CD103+TRM was not obvious
    .
    CD103+TRM showed high expression of GzmA and high expression of IFN-g
    in CD103-T cells.
    Before secondary infection, CD103+TRM expressed known markers homing receptor CCR9 and ITGAE CTLA4 GzmA, while CD103-TRM expressed migration markers CCR7 CCR2 and S1PR1, indicating higher proliferation and migration
    .
    After secondary infection, the transcription response of CD103-TRM was higher overall, and the expression levels of cytokines and chemokines were high, indicating that CD103+TRM cells were more limited in response to stimuli
    .
    The authors suggest that CD103+CD8+TRM can monitor
    tissue infections in a TCR and antigen-independent manner.
    At the same time, CD103+CD8+TRM compositionally expressed GzmA, which was ready
    for lysis of target cells.
    CD103+CD8+TRM promotes the formation of immune synapses and the release of lytic cell mediators through integratin-mediated adhesion epithelial cells to target infected cells
    in tissues.
    These results suggest that cell localization and interaction of TRM require different mechanisms to mediate immune surveillance and tissue protection
    .

    Secondary infection T cell response pattern mapThese
    two studies reveal new insights
    into TRM cell heterogeneity, function, and cell maintenance.
    CD103+CD8+TRM is more closely related to resident tissues to better act on target cells, and CD103-TRM can contribute to
    supplementing and increasing the pool of mature TRM cells.
    Understanding the different functional response subsets of TRM provides a more comprehensive cellular basis
    for vaccination strategies and immunomodulatory therapies.


    Isaac J.
    Jensen and Donna L.
    Farber from Columbia University collaborated on the two articles titled
    Gutsy memory T cells stand their ground against pathogens Reviews of the article
    .

    Original link:

    1.
    http://doi.
    org/ 10.
    1126/sciimmunol.
    abl9925

    2.
    http://doi.
    org/10.
    1126/sciimmunol.
    abp9553


    Platemaker: Eleven


    Reprint instructions

    【Original article】BioArt original article, welcome to share by individuals, reproduction is prohibited without permission, the copyright of all works published is owned by BioArt
    .
    BioArt reserves all statutory rights and violators will be prosecuted
    .


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.